Showing 341 - 360 results of 100,735 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (nn decrease)) ))', query time: 1.33s Refine Results
  1. 341

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. …”
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346

    The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

    Published 2022
    “…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”
  7. 347
  8. 348

    Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer by Li Xu (108702)

    Published 2018
    “…We screened for CHD 9 expression using immunohistochemical analysis in 87 surgical CRC specimens and found that the expression was upregulated in 81.5% of the cases, while 7.4% were decreased; in the remaining 11.1% of the cases, levels were not altered. …”
  9. 349
  10. 350

    Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355

    sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

    Published 2015
    “…When analyzed separately based upon treatment, the decrease in sC5b-9 levels was due to a decrease in patients treated with mycophenolate mofetil (P < 0.001 by linear regression; n = 12 for all time-points). …”
  16. 356

    Purified serum IgG from SPMS patients decreased the amount of claudin-5 protein, and IgG from all clinical subtypes of MS patients increased the amount of VCAM-1 protein in TY09 ce... by Fumitaka Shimizu (545145)

    Published 2014
    “…(G) The amount of VCAM-1 protein in the TY09 cells was significantly increased after exposure to the purified IgG fraction from patinets with all clinical subtypes of MS, whereas it was not changed by the IgG from healthy controls, as determined by a Western blot analysis. (H) The TEER value of the TY09 cells was significantly decreased after exposure to the purified IgG fraction from SPMS patients, although it was not changed by incubation with the purified serum IgG fractions from RRMS-R or RRMS-S patients, or from healthy controls (mean ± SEM, SPMS n = 6, RRMS-R n = 4, RRMS-S n = 6, Normal n = 5). …”
  17. 357
  18. 358
  19. 359
  20. 360